DK346486D0 - Aminosalicylsyrederivater og farmaceutiske midler - Google Patents

Aminosalicylsyrederivater og farmaceutiske midler

Info

Publication number
DK346486D0
DK346486D0 DK346486A DK346486A DK346486D0 DK 346486 D0 DK346486 D0 DK 346486D0 DK 346486 A DK346486 A DK 346486A DK 346486 A DK346486 A DK 346486A DK 346486 D0 DK346486 D0 DK 346486D0
Authority
DK
Denmark
Prior art keywords
acid derivatives
pharmaceutical agents
aminosalicylic acid
aminosalicylic
pharmaceutical
Prior art date
Application number
DK346486A
Other languages
Danish (da)
English (en)
Other versions
DK346486A (da
Inventor
Giancarlo Sportoletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of DK346486D0 publication Critical patent/DK346486D0/da
Publication of DK346486A publication Critical patent/DK346486A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK346486A 1984-11-29 1986-07-21 Aminosalicylsyrederivater og farmaceutiske midler DK346486A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria
PCT/EP1985/000645 WO1986003199A1 (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK346486D0 true DK346486D0 (da) 1986-07-21
DK346486A DK346486A (da) 1986-07-21

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
DK346486A DK346486A (da) 1984-11-29 1986-07-21 Aminosalicylsyrederivater og farmaceutiske midler

Country Status (12)

Country Link
EP (1) EP0236329A1 (es)
JP (1) JPS62501703A (es)
KR (1) KR870700608A (es)
CN (1) CN85109554A (es)
AU (1) AU5231186A (es)
DK (1) DK346486A (es)
ES (1) ES8701717A1 (es)
GR (1) GR852834B (es)
IT (1) IT1196348B (es)
PT (1) PT81566B (es)
WO (1) WO1986003199A1 (es)
ZA (1) ZA859035B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (it) * 1990-09-12 1994-09-12 Depha Team Srl Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
ATE275127T1 (de) * 2000-04-19 2004-09-15 Neurotech Co Ltd Verbindungen, zusammensetzungen und verfahren zur vorbeugung der neurodegeneration bei akuten oder chronischen verletzungen des zentralen nervensystems
US6573402B1 (en) 2000-04-20 2003-06-03 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
DE60114724T2 (de) * 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose
DE60141725D1 (de) 2001-01-19 2010-05-12 Apex Biotechnology Corp Nicht enzymatischer Einwegerkennungselektrodenstreifen der einen oberflächenaktiven Stoff beinhaltet, zum Nachweis von Harnsäure; Herstellungsverfahren dafür und Verwendung davon
US7595343B2 (en) 2001-09-14 2009-09-29 Methylgene, Inc. Inhibitors of histone deacetylase
ES2568491T3 (es) 2002-06-19 2016-04-29 Gnt Pharma Co., Ltd. Derivados de tetrafluorobencilo y composición farmacéutica para prevenir y tratar enfermedades neurodegenerativas agudas y crónicas en el sistema nervioso central que contiene dichos derivados
KR100668111B1 (ko) 2005-07-28 2007-01-12 (주)에스에이치제약 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법
CN101538218B (zh) 2006-04-13 2013-05-29 纽若泰克制药株式会社 用于治疗或预防退行性和炎症性疾病的药物组合物
CN100422721C (zh) * 2006-05-26 2008-10-01 南京大学 一种利用糖基萘酚的铝离子检测方法
EP2201946A4 (en) * 2007-10-23 2012-01-25 Inst Med Molecular Design Inc HAMMER OF PAI-1 PRODUCTION
KR100852962B1 (ko) 2007-11-12 2008-08-20 주식회사 뉴로테크 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
MX2011000273A (es) 2008-07-08 2011-05-23 Catabasis Pharmaceuticals Inc Salicilatos acetilados con acidos grasos y sus usos.
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
KR101204108B1 (ko) * 2009-02-09 2012-11-22 주식회사 지엔티파마 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
SG10201500431SA (en) 2009-09-01 2015-03-30 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
US9498461B2 (en) * 2012-05-23 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
US9822135B2 (en) * 2012-10-30 2017-11-21 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 dimerization inhibitors
AU2019412533A1 (en) * 2018-12-28 2021-07-15 Gnt Pharma Co., Ltd. Compositions and methods for treating neurodegenerative disorders
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (es) * 1964-06-09 1966-11-02
NL7008623A (es) * 1969-06-25 1970-12-29
JPS5640710B2 (es) * 1973-01-18 1981-09-22
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
IT1196348B (it) 1988-11-16
PT81566B (en) 1987-04-07
IT8423799A0 (it) 1984-11-29
ES8701717A1 (es) 1986-12-01
GR852834B (es) 1986-03-27
ZA859035B (en) 1986-08-27
KR870700608A (ko) 1987-12-30
EP0236329A1 (en) 1987-09-16
CN85109554A (zh) 1986-07-23
DK346486A (da) 1986-07-21
JPS62501703A (ja) 1987-07-09
PT81566A (en) 1985-12-01
WO1986003199A1 (en) 1986-06-05
ES549359A0 (es) 1986-12-01
AU5231186A (en) 1986-06-18

Similar Documents

Publication Publication Date Title
DK346486D0 (da) Aminosalicylsyrederivater og farmaceutiske midler
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK340088D0 (da) Aminosyrederivater
DK475684A (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
DK497685D0 (da) Ketongruppeholdige oxindol-3-carboxamid-derivater og laegemiddel indeholdende saadanne derivater
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK523288A (da) Aminosyrederivater
DK435688A (da) Farmaceutiske midler
KR870700618A (ko) 크로모글릭산유도체와 그 제조방법 및 약학적 조성물
NO883082D0 (no) Substituerte alkenkarboksylsyreamider og derivater.
DK166878C (da) Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK489584A (da) 6alfa-(1-hydroxyethyl)-2-azacycloalkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK422984D0 (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK60187D0 (da) Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser
DK151785A (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DK162987C (da) 5-amino-2-oe3-(3-piperidinomethylphenoxy)propylaminoaa-4(3h)-pyrimidon og farmaceutisk acceptable syreadditionssalte deraf
DK553285D0 (da) Fenoxypropanolaminsalte og farmaceutiske praeparater deraf
IS2998A7 (is) Ný phenoxypanolamine sölt og lyfjablöndur úr þeim
DK197085D0 (da) Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
DK491785A (da) Benzoesyrederivater og fremstilling deraf
DK162288A (da) Benzoesyrederivater og anvendelse deraf
DK726588A (da) Farmaceutiske midler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment